News
Settlement may compensate consumers who bought Robitussin cough medicine products that were falsely marketed as "non-drowsy." ...
Robitussin owes some cold sufferers money as part of a class-action settlement. The cough medicine brand has agreed to pay $4.5 million to resolve claims that it duped consumers by marketing its ...
In the US, the maker of Robitussin cough syrup is recalling several products containing honey due to contamination. If you're someone reaching for cough syrups reguarly during cold spells you're ...
Robitussin was at the center of a class-action complaint over its “non-drowsy” cough and cold medicines. Screengrab from Calchi, et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results